ADVOCATE CHRIST HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $5.9M
- Transactions
- 948
- Companies
- 40
- Average per transaction
- $6,232
Who reported the payments
| Eli Lilly | $1,047,386 |
| Amgen | $475,884 |
| AstraZeneca | $474,068 |
| Boston Scientific | $454,618 |
| Takeda Pharmaceuticals U.S.A., Inc. | $355,461 |
| Jazz Pharmaceuticals Inc. | $285,750 |
| Janssen Research & Development, LLC | $256,054 |
| Angiodynamics, Inc. | $211,000 |
| Bristol Myers Squibb | $204,342 |
| Novartis | $191,097 |
| Karyopharm Therapeutics Inc. | $186,859 |
| Edwards Lifesciences | $169,026 |
| Bayer | $166,750 |
| Merck | $155,081 |
| Abbott | $117,520 |
| Microvention, Inc. | $98,864 |
| Stryker | $94,835 |
| Exact Sciences | $83,614 |
| Gilead | $80,798 |
| Atricure, Inc. | $71,814 |
| Penumbra, Inc. | $68,800 |
| Procyrion, Inc. | $54,169 |
| Biogen | $43,720 |
| AbbVie | $37,330 |
| W. L. Gore & Associates, Inc. | $34,300 |
| Regeneron | $33,832 |
| Pfizer | $33,000 |
| Rapid Medical Ltd | $31,860 |
| E.r. Squibb & Sons, L.L.C. | $29,390 |
| Route 92 Medical, Inc. | $25,194 |
| National Marrow Donor Program | $24,045 |
| Heartflow, Inc. | $19,250 |
| Johnson & Johnson | $19,000 |
| United Therapeutics Corporation | $15,500 |
| Ipsen Biopharmaceuticals, Inc | $15,500 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $14,000 |
| Vertex | $11,506 |
| ERBE USA Inc | $11,000 |
| Daiichi Sankyo Inc. | $10,815 |
| Mirati Therapeutics, Inc. | $10,565 |